
Imricor Medical Systems Inc
ASX:IMR

Operating Margin
Imricor Medical Systems Inc
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | Company | Market Cap |
Operating Margin |
||
---|---|---|---|---|---|
US |
![]() |
Imricor Medical Systems Inc
ASX:IMR
|
358m AUD |
-1 699%
|
|
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
217.3B USD |
18%
|
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
183.4B USD |
28%
|
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
153.6B USD |
19%
|
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
150.6B USD |
22%
|
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
116.9B USD |
20%
|
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
51.4B EUR |
14%
|
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
51.6B USD |
13%
|
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
45.1B USD |
28%
|
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
42.7B USD |
29%
|
|
US |
![]() |
Resmed Inc
NYSE:RMD
|
39.1B USD |
32%
|
Imricor Medical Systems Inc
Glance View
Imricor Medical Systems, Inc. is a medical device company, which engages in the design, manufacture, and distribution of magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures. The company is headquartered in Burnsville, Minnesota. The company went IPO on 2019-08-30. The firm is engaged in designing, manufacturing, and selling MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias. Its products include Vision-mitral regurgitation (MR) Ablation Catheter, Advantage-MR electrophysiology (EP) Recorder/Stimulator and Vision-MR Dispersive Electrode. The Vision-MR Ablation Catheter is designed to work under real-time MRI guidance. Advantage-MR EP Recorder/Stimulator System provides technology that allows physicians to utilize both the EP recording system and a cardiac stimulator while ablating within the iCMR environment. The firm sells its products to hospitals and clinics for use in iCMR labs, in which ablation procedures using the Vision-MR Ablation Catheter can be performed.

See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Imricor Medical Systems Inc's most recent financial statements, the company has Operating Margin of -1 698.6%.